Skip to main content
. 2015 Jun 5;3(7):615–617. doi: 10.1002/ccr3.269

Table 1.

Diagnosis and treatment timeline

Aug-12 Feb-13 May-13 Jun-13 Sep-13 Nov-13 Jan-14 Feb-14 Apr-14 May-14 Jun-14
Diagnosed with CLL FCR × 6 cycles CT scan demonstrated recurrence Rituximab and Bendamustine × 2 cycles Ofatumumab × 5 cycles R-EPOCH × 4 cycles Richter confirmed. PET scan no response R-ICE × 1 cycle; R-DHAC × 3 PET scan without response Ibrutinib 420 mg daily and Rituximab weekly × 5 PET response – eligible for transplant

CLL, chronic lymphocytic leukemia; FCR, fludarabine, cyclophosphamide, and rituximab.